Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic Merkel cell carcinoma previously treated with chemotherapy: Results of the phase 2 JAVELIN Merkel 200 trial Meeting Abstract
| Authors: | Kaufman, H.; Russell, J. S.; Hamid, O.; Bhatia, S.; Terheyden, P.; D'Angelo, S. P.; Shih, K. C.; Lebbe, C.; Linette, G. P.; Milella, M.; Brownell, I.; Lewis, K. D.; Lorch, J. H.; Chin, K. M.; Mahnke, L.; von Heydebreck, A.; Cuillerot, J. M.; Nghiem, P. |
| Abstract Title: | Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic Merkel cell carcinoma previously treated with chemotherapy: Results of the phase 2 JAVELIN Merkel 200 trial |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 486s |
| Language: | English |
| ACCESSION: | WOS:000404711507130 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.9508 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9508 -- Source: Wos |
